After months of advocacy from faith and global-health communities, Congress decided in last minute negotiations this week to ...

WHO recommends twice-yearly injectable lenacapavir for HIV prevention, expanding PrEP options for key populations.

A major HIV drug maker will return $202 million nationwide after a multi-year investigation and settlement. Pharmaceutical ...

A new kind of HIV prevention is making it easier for those at risk to stay protected, thanks to a twice-yearly injection now ...

Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

The move to save PEPFAR funding may prove useful in rallying GOP support from powerful lawmakers like Senate Appropriations ...

As Black women are being hit with new HIV cases, stars such as Tamar Braxton is unapologetically shining a light on HIV ...

At Essence Festival’s Global Black Economic Forum, Braxton joined Dr. Contessa and Raheem DeVaughn to speak candidly about HIV prevention, breast health, and taking control of your body.

The White House’s decision to safeguard $400m in President’s Emergency Plan for AIDS Relief (PEPFAR) funding to support the global human immunodeficiency virus (HIV) emergency provides “hope” to ...

PEPFAR has saved more than 25 million lives since its inception. It has strengthened health systems and helped stabilize ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...